Intestinal neuroendocrine neoplasm

Summary

Intestinal neuroendocrine neoplasm (MONDO:0002883) is a cancer. A subtype of intestinal neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	intestinal neuroendocrine neoplasm
Mondo ID	MONDO:0002883
DOID	DOID:4119
NCIT	C5695
UMLS	C1334231
MedGen	233567
GARD	0023287
Anatomy (UBERON)	UBERON:0000160
Is cancer (heuristic)	yes

Also known as: intestinal neuroendocrine benign tumour · intestinal neuroendocrine neoplasm · intestine NET · intestine neuroendocrine neoplasm · intestine neuroendocrine tumor · intestine neuroendocrine tumor, well differentiated, low or intermediate grade · intestine neuroendocrine tumour · neuroendocrine neoplasm of intestine · neuroendocrine neoplasm of the intestine

Disease family

This is a subtype of intestinal neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › intestinal neoplasm › intestinal neuroendocrine neoplasm

Related subtypes (5): intestinal benign neoplasm, small intestine neoplasm, colorectal neoplasm, intestinal cancer, epithelial tumor of anal canal

Subtypes (4): colon neuroendocrine neoplasm, rectum neuroendocrine neoplasm, small intestine neuroendocrine neoplasm, intestinal neuroendocrine tumor G1

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.